Literature DB >> 4191890

Ascorbic acid in the prevention and treatment of toxic effects from chromates.

M H Samitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4191890     DOI： 102340/00015555505964

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  6 in total

1.  [Experimental chromium allergy of animals. The influence of valences and chemical properties of chromium ions (author's transl)].

Authors:  H W Schneeberger; G Forck
Journal:  Arch Dermatol Forsch       Date:  1974

2.  Reduction of hexavalent chromium by ascorbic acid in rat lung lavage fluid.

Authors:  Y Suzuki
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

3.  Experimental bases for ascorbic acid therapy of poisoning by hexavalent chromium compounds.

Authors:  U Korallus; C Harzdorf; J Lewalter
Journal:  Int Arch Occup Environ Health       Date:  1984       Impact factor: 3.015

4.  Neoplastic transformation of human bronchial cells by lead chromate particles.

Authors:  Hong Xie; Amie L Holmes; Sandra S Wise; Shouping Huang; Cheng Peng; John Pierce Wise
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-21       Impact factor: 6.914

5.  Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung.

Authors:  Y Suzuki; K Fukuda
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

Review 6.  Adverse hematological effects of hexavalent chromium: an overview.

Authors:  Rina Rani Ray
Journal:  Interdiscip Toxicol       Date:  2017-05-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.